home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630431.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
3KB
|
44 lines
Document 0431
DOCN M9630431
TI Clinical significance of serum 2,5-oligoadenylate synthetase and soluble
interleukin-2 receptor in hemophiliacs positive and negative for human
immunodeficiency virus type 1.
DT 9603
AU Matsuda J; Gotoh M; Gohchi K; Tsukamoto M; Saitoh N; Kinoshita T;
Department of Medicine, Teikyo University School of Medicine,; Tokyo,
Japan.
SO Clin Diagn Lab Immunol. 1994 Mar;1(2):155-9. Unique Identifier :
AIDSLINE MED/96050798
AB We measured serum 2,5-oligoadenylate synthetase (2,5-AS) levels and
soluble interleukin-2 receptor (sIL-2R) levels in human immune
deficiency virus type 1 (HIV-1)-positive and HIV-1-negative hemophiliacs
in order to clarify the clinical significance of these parameters in
hemophiliacs. Serum 2,5-AS levels were measured by a radioimmunosorbent
assay, and sIL-2R levels were measured by an enzyme-linked immunosorbent
assay. The mean serum 2,5-AS levels were higher in AIDS-related-complex
and AIDS patients, asymptomatic carriers, and HIV-1-negative
hemophiliacs than in hepatitis C virus-positive patients and healthy
controls. Serial determinations showed that the 2,5-AS levels tended to
increase in HIV-1-positive patients, especially those with AIDS-related
complex or AIDS, although it showed a substantial decrease in the
terminal stage. The serum sIL-2R levels were higher in HIV-1-positive
patients, HIV-1-negative patients, and hepatitis C virus-positive
patients than in controls. Serial studies showed little change in the
HIV-1-positive and HIV-1-negative groups, although sIL-2R levels showed
a tendency to decrease with zidovudine treatment. On the basis of the
present results, we may well conclude that 2,5-AS and sIL-2R are not
specific markers for hemophiliacs with HIV-1 infection. However, serial
measurement of these markers can still be useful for assessing the
progression of AIDS and the prognosis for patients with AIDS, as well as
for monitoring the response to zidovudine.
DE Adolescence Adult Biological Markers/BLOOD
Hemophilia/*ENZYMOLOGY/IMMUNOLOGY Hepatitis C/ENZYMOLOGY/IMMUNOLOGY
Human HIV Seronegativity/*IMMUNOLOGY HIV Seropositivity/DRUG
THERAPY/*ENZYMOLOGY/IMMUNOLOGY Middle Age Receptors,
Interleukin-2/*ANALYSIS Support, Non-U.S. Gov't Zidovudine/THERAPEUTIC
USE 2',5'-Oligoadenylate Synthetase/*BLOOD JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).